March 11, 2026/
The most common diseases affecting women, their causes, and the critical role of pharmacovigilance in ensuring medication safety. We explore drug-induced conditions that disproportionately affect women,...
ALVigiLance is a dedicated pharmacovigilance platform designed to support the healthcare team in ensuring safer medication use. Our mission is simple yet vital: to provide trusted insights, practical tools, and up-to-date resources that empower healthcare professionals to identify, prevent, and manage adverse drug reactions (ADRs).
Simplified, practical guides on drug safety and monitoring.
Real-world examples to strengthen your clinical decision-making.
Summaries of global drug warnings and regulatory actions.
Strategies for adverse event reporting, risk management, and patient counseling.
To create a proactive community of healthcare providers who champion medication safety and improve patient outcomes through shared knowledge and vigilance.
Medication safety is everyone’s responsibility. Explore, learn, and engage with ALVigiLance — because together, we can reduce risks and save lives.
The most common diseases affecting women, their causes, and the critical role of pharmacovigilance in ensuring medication safety. We explore drug-induced conditions that disproportionately affect women,...
Presents critical safety information for healthcare professionals, including a label update on drug‑induced aseptic meningitis, a local case report of excessive infant sleep following maternal escitalopram...
With over 6,000 identified rare diseases and millions of medical devices in daily use worldwide, standardized adverse event reporting is critical for public health safety.
